Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Artgen reported for 2023 by RAS

4/1/24 ABIO

Sovcombank reported for 2023 by RA

4/1/24 SVCB

Rosneft resumes buyback

4/1/24 ROSN

Uralsib reported for 2023 by RAS

4/1/24 USBN

Yandex was listed on Moscow Exchange

4/1/24 YNDX

TGC-2 reported for 2023 by RAS

4/1/24 TGKB

Rostelecom and partners will develop import-independent PACs for fuel and energy sector

4/1/24 RTKM

Severstal shuts down blast furnace at CherMK

4/1/24 CHMF

Moscow Exchange suspends trading in X5 Retail Group receipts

4/1/24 X5

Magnit.Market opened the first points of delivery of orders

4/1/24 MGNT